This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San DiegoLive In-Person Event: December 14 - 17, 2025

Dr. Gregory Brittingham, PhD
Director of Product at Neochromosome
Speaker

Profile

Greg Brittingham, Ph.D. is the Director of Product at Neochromsome, where he leads product development of innovative platform technologies based on Neochromosome’s genome-scale cell engineering technology. Greg received his Ph.D. from New York University, where he studied cell and computational biology. During his PhD, Greg discovered that mTOR signaling enables ‘crowd control’ by drastically altering the physical properties of the cell and regulating the diffusion of large macromolecules via ribosome concentration.

Agenda Sessions

  • neoSwitch™: A Switchable Yeast Platform and Robotic Workflow for VHH & ScFv Discovery

    12:05pm